Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Protagonist Therapeutics Insider Sold Shares Worth $18,240,568, According to a Recent SEC Filing

Protagonist Therapeutics Insider Sold Shares Worth $18,240,568, According to a Recent SEC Filing

MT newswireMT newswire2026/09/11 07:23
03:23 AM EDT, 09/11/2026 (MT Newswires) -- Dinesh V Patel, Director, President and Chief Executive Officer, on September 08, 2026, sold 125,000 shares in Protagonist Therapeutics (PTGX) for $18,240,568. Following the Form 4 filing with the SEC, Patel has control over a total of 522,968 common shares of the company, with 522,968 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1377121/000110465926106831/xslF345X05/tm2625158-1_4seq1.xml
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!